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Background: In Japan, many carbon monoxide (CO) poisoning cases are transported to emergency settings,
making treatment and prognostic assessment an urgent task. However, there is currently no reliable means to
predict whether “delayed neuropsychiatric sequelae (DNS)” will develop after acute CO poisoning. This study is
intended to find out risk factors for the development of DNS and to characterize the clinical course following the
development of DNS in acute CO poisoning cases.
Methods: This is a retrospective cohort study of 79 consecutive patients treated at a single institution for CO
poisoning. This study included 79 cases of acute CO poisoning admitted to our emergency department after
attempted suicide, who were divided into two groups consisting of 13 cases who developed DNS and 66 cases
who did not. The two groups were compared and analyzed in terms of clinical symptoms, laboratory findings, etc.
Results: Predictors for the development of DNS following acute CO poisoning included: serious consciousness
disturbance at emergency admission; head CT findings indicating hypoxic encephalopathy; hematology findings
including high creatine kinase, creatine kinase-MB and lactate dehydrogenase levels; and low Global Assessment
Scale scores. The clinical course of the DNS-developing cases was characterized by prolonged hospital stay and a
larger number of hyperbaric oxygen (HBO) therapy sessions.
Conclusion: In patients with the characteristics identified in this study, administration of HBO therapy should be
proactively considered after informing their family, at initial stage, of the risk of developing DNS, and at least
5 weeks’ follow-up to watch for the development of DNS is considered necessary.
Keywords: Delayed encephalopathy, Carbon monoxide poisoning, Delayed neuropsychiatric sequelae,
Suicide attempt, Psychiatric emergencyBackground
Carbon monoxide (CO) poisoning has been a preferred
method of suicide due to its high success rate of approxi-
mately 30% [1], its simplicity, and the minimal external
injury involved. According to the 2011 “White Paper
on Suicide (Jisatsu Taisaku Hakusho)” compiled by the
Japanese Cabinet Office, “briquettes or similar materials”
were the second most used means of suicide used by men
(2,137 persons, 10.2%), next only to “hanging” (14,354 per-
sons, 68.5%), with their use spread across a wide range of* Correspondence: kudok@iwate-med.ac.jp
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reproduction in any medium, provided the orage groups from those in their twenties to those in their
sixties [2].
In general, CO poisoning occurs due to such causes as
inhalation of exhaust gas from automobiles, or incomplete
combustion of charcoal, briquettes, fuel gas or oil in a
closed place, or in such settings as a fire. Its pathology con-
sists mainly of dysfunction of various organs due to tissue
hypoxia. Since hypoxia is reversible, early removal of CO is
essential and high levels of oxygen should be administered
wherever possible during transportation, examination and
treatment. Means to administer high concentrations of
oxygen include normobaric oxygen (NBO) and hyperbaric
oxygen (HBO) therapies. Previous studies comparing the
two therapies have reported that HBO therapy is effectivetd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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its severity in cases of acute CO poisoning [3-6]. Other
studies, however, have disputed that finding, so there is still
worldwide controversy regarding the effectiveness of HBO
therapy [7]. In addition, various studies worldwide have
cited different criteria for administering HBO therapy dur-
ing acute CO poisoning due to the ambiguity of indices of
the clinical severity of acute CO poisoning. Criteria for ad-
ministering HBO therapy have yet to be standardized.
Moreover, a patient transfer from a medical facility with no
HBO chamber to a facility with an HBO chamber has to
be considered [8].
CO poisoning is generally classified as acute CO poison-
ing or chronic CO poisoning depending on the duration
of CO exposure. CO poisoning is categorized into differ-
ent forms based on the clinical manifestations resulting
from CO exposure over time. With acute CO poisoning,
the patient recovers without sequelae, but with delayed
CO poisoning or intermittent CO poisoning the patient
can be left with neurologic sequelae.
Delayed CO poisoning refers to impaired consciousness
that develops at the time of poisoning and that persists
without improving. This form of poisoning causes brain
cells to be deprived of oxygen and can lead to sequelae
such as amnestic syndrome, loss of initiative, affective in-
continence, and parkinsonism [9]. Intermittent CO poi-
soning is pathology where, after a certain asymptomatic
period (from several days to four weeks; an average of two
weeks) following recovery from acute-phase symptoms,
neuropsychiatric symptoms develop rapidly, such as am-
nesia, disorientation, loss of mathematical ability, slowness
of movement, urinary incontinence, apathy, anxiety or
emotional lability. These symptoms may lead to Apallic
syndrome in some cases and/or to death in worst cases
[5]. Intermittent CO poisoning is thought to develop as a
result of the progression of focal demyelination of the
cerebral white matter and subsequent neuronal death.
Intermittent CO poisoning has been reported to occur in
2.8% of acute CO poisoning cases and 11.8% of those who
were hospitalized [10]. These two types of CO poisoning
are sometimes referred to collectively as “delayed neuro-
psychiatric sequelae (DNS).”
Iwate Medical University Hospital (“Hospital”) has an
HBO chamber, and its emergency department accepts
more than 10 cases of attempted suicide with CO poison-
ing annually. The Hospital sometimes accepts CO poison-
ing cases in a very acute phase from neighboring medical
institutions with no HBO chamber. Virtually all of these
cases have been hospitalized after admission and have re-
ceived treatment including HBO therapy, with some de-
veloping DNS and remaining having been hospitalized for
prolonged periods.
While it is necessary to predict the potential develop-
ment of DNS at the initial stage following admission tothe emergency department, no correlation has been found
between CO-Hb level in the blood and clinical severity
[11]. It has also been found impossible to predict prognosis
from EEG findings obtained at the initial stage [12]. Based
on the fact that DNS is caused by demyelinating changes in
the cerebral white matter, some researchers have pointed
out the need to measure myelin basic protein (MBP) levels
in the cerebrospinal fluid (CSF) soon after injury [13], as
well as to assess nerve fibers in the white matter by diffu-
sion tensor imaging [14] or 1H-magnetic resonance spec-
troscopy [15]. However, since head MRI depicts all the
various histological changes, it may not be possible to ac-
curately tell the progress of the condition in the cerebral
white matter [16]. In addition, there have been cases who
developed DNS despite having subnormal MBP levels in
the CSF two weeks immediately following injury [17]. A re-
cent study examined development of cognitive sequelae
and genetic factors 6 weeks after CO poisoning. The study
found that the apolipoprotein (APOE) epsilon4 allele was
not associated with development of cognitive sequelae [18].
Taken together, at present no reliable means to predict
DNS have been established, making prediction during the
acute phase difficult.
However, if the development of DNS can be predicted
during the acute phase, it would help making decisions on
treatment strategy, by such means as identifying cases to
which HBO therapy should be actively administered and
setting an appropriate period of hospital treatment. In the
present study, we studied cases of attempted suicide with
acute CO poisoning admitted to our emergency depart-
ment, and reviewed and analyzed these cases with the
intention of identifying risk factors for developing DNS
and characterizing the clinical course after the develop-
ment of DNS.
Methods
This is a retrospective cohort study of 79 consecutive
patients treated at a single institution for CO poisoning.
This study included 79 cases who were admitted to the
Hospital’s emergency department due to CO poisoning
after attempted suicide during the period between 2002
and 2011. All subjects were divided into two groups,
consisting of 13 cases who developed DNS and 66 cases
who did not, and were reviewed for clinical symptoms
and laboratory findings at admission to the emergency
department, circumstances of injury, treatment received
during the acute phase, and other information to the ex-
tent available in the emergency department setting.
Patient medical records were retrospectively reviewed,
and patients who developed DNS and patients who did
not develop DNS were compared in terms of 16 items:
gender, age, location of exposure, estimated duration of
exposure, whether or not the patient was transported from
another hospital, severity of impaired consciousness (i.e.,
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seen at a hospital [19], CO-Hb level when the patient was
first seen at a hospital, white blood cell (WBC) count and
CK, CK-MB, and LDH levels on the day the patient was
seen, whether or not there were abnormal findings from a
head CT scan when the patient was first seen, whether or
not HBO therapy was administered on the day the patient
was seen, diagnostic category according to “Mental and
behavioural disorders” in the International Classification
of Diseases, Tenth Revision (ICD-10) [20], duration of
hospital stay, and number of sessions of HBO therapy.
In addition, the patients were assessed in terms of
their psychiatric symptoms using a Japanese version (by
Kitamura, et al.) [21] of the Oxford University version
of the Brief Psychiatric Rating Scale (BPRS), and were
also investigated in terms of their general psychiatric
symptoms and abilities of daily living using a Japanese
translation by Kitamura, et al. of the Global Assessment
Scale (GAS) [22]. Furthermore, the patients’ life events
prior to their attempted suicide were assessed using the
Life Change Units (LCU) of the Holmes Social Readjust-
ment Rating Scale [23].
Note that JCS scores and CO-Hb levels used in this
study were those obtained at the first medical institution,
not necessarily the Hospital, to which each patient was
admitted in emergency, since quite a few cases were
transferred to the Hospital under oxygen administration
after consultation at another medical institution.
Assessment and diagnosis of each review item were
performed by an emergency psychiatrist or the Hospital’s
psychiatrist on duty.
Statistical processing was performed using SPSS 17.0J for
Windows. Testing of mean values, ratios and JCS scores
was conducted using one-way analysis of variance, a chi-
square test and the Mann-Whitney U test, respectively. In
all tests, the level of significance was 5%, with significance
probabilities being expressed in numbers.
This study is a chart review study and we did not ob-
tain informed consent. Personally identifiable informa-
tion was excluded from data. Consideration was given to
the protection of personal information in the process of
data management and processing. This study was con-
ducted with the approval of the Ethics Committee of the
Iwate Medical University, School of Medicine.
Results
The mean age of all 79 cases was 40.44 years (men, 43.0 ±
14.23 years; women, 35.0 ± 12.57 years). Nineteen cases
(24%) were transferred to the Hospital from their previous
respective medical institutions to which they were first
brought, on the grounds of difficulty providing care. The
13 cases who developed DNS consisted of 11 men and 2
women and had a mean age of 47.38 ± 14.83 years, two of
who had been transferred from another hospital. In termsof type of DNS, 5 cases had intermittent CO poisoning,
whereas the remaining 8 cases included cases of prolonged
CO poisoning and those of persistent apallic syndrome
(see the Table 1). The mean period before the onset of
intermittent CO poisoning was 23.2 days of illness.Patients’ background and circumstances
While the mean age was higher in the DNS-developing
group by approximately 7 years, there was no significant
difference between the two groups. Although approxi-
mately 80% of all cases were men, there was no signifi-
cant difference in the development of DNS between
male and female cases. Place of exposure to CO was
broadly classified into car and room, with no significant
difference between the DNS-developing and non-DNS-
developing groups. Estimated duration of exposure was
unknown for approximately 50% of all cases, with no
significant difference between the DNS-developing and
non-DNS-developing groups.
Physical findings and laboratory results at
first consultation
The patients in the DNS-developing group had signifi-
cantly more severe consciousness disturbance (in terms of
mean JCS score) at the time of first hospital consultation
(p<0.001). A significantly higher proportion of these pa-
tients showed abnormal head CT findings indicating hyp-
oxic encephalopathy (p<0.001). Hematology results showed
that these patients also had significantly higher CK, CK-MB
and LDH levels (p = 0.001, p<0.001 and p<0.001, respect-
ively). The GAS scores of these patients, which assess their
psychiatric symptoms, tended to be significantly lower than
in the non-DNS-developing group (p = 0.033).
Overall, F3 was the single most common main diagnosis
according to ICD-10, followed by F4, which was a ten-
dency also shared by both groups. Severity of psychiatric
symptoms (BPRS score) and life events (mean LCU score)
showed no significant difference between the groups.
CO-Hb levels at the time of first hospital consultation
were higher in the non-DNS-developing group, whereas
WBC count was higher in the DNS-developing group,
with neither showing a significant difference.
Clinical course after hospitalization
Of the items to assess the clinical course after hos-
pitalization, length of hospital stay (p<0.001) and the
number of HBO therapy sessions (p<0.001) showed a
significant difference between the two groups, with the
DNS-developing group having longer hospital stay and
a larger number of sessions. In the DNS-developing
group, the period of time before the onset of intermit-
tent CO poisoning ranged from 17 to 35 days (mean:
23.2 days of illness). Whether or not HBO therapy was
Table 1 Comparison of characteristics between the delayed neuropsychiatric sequelae (DNS)-developing group and the
non-DNS-developing group
Item Category DNS-developing group Non-DNS-developing group P value
n = 13 n = 66
Gender Male (%) 11 (84.6) 54 (81 8) 1.000
Female (%) 2 (15.4) 12 (18.2)
Mean age ± S.D. (years) 47.38 ± 1483 40 44 ± 1391 108.000
Place of exposure Car (%) 10 (76.9) 47 (71.2) 1.000
Room (%) 3 (23.1) 19 (28.8)
The number of the transfered from outside institution (%) 2 (15.4) 17(25.8) 0.723
Time to onset of intermittent CO poisoning (day) 23.2
Mean duration of exposure ± SD (min) 310.00 ± 242.49 253.33 ± 199.93 0.644
Mean JCS score at first hospital consultation ± S.D. 200.4 ± 107.24 52.71 ± 94.55 0.000*
Abnormal head CT findings at consultation Yes (%) 10 (76.9) 4 (6.2) 0.000#
No (%) 3 (23.1) 61 (93.8)
CO-Hb level at first hospital consultation ± S.D. (%) 19.58 ± 20.03 24.99 ± 13.98 2.242
Mean WBC count ± S.D. (/μ) 14391.52 ± 4534.60 13834.44 ± 10769.56 0.856
Mean CK level ± S.D. (IU/L) 4371.92 ± 5976.33 650.86 ± 2384.67 0.001I†
Mean CK-MD level ± S.D. (IU/L) 51.22 ± 33.28 15.66 ± 23.47 0.000†
Mean LDH level ± S.D. (U/L) 395.80 ± 270.04 221.87 ± 101.95 0.000†
HBO therapy administered at consultation? Yes 10 (76.9) 39 (59.1) 0.350
No 3 (23.1) 27 (40.9)
Total BPRS score ± S.D. 14.31 ± 11.86 14.58 ± 9.124 0.925
GAS ± S.D. 17.31 ± 18.50 28.48 ± 16.70 0.033†
LCU ± S.D. 50.40 ± 15.05 65.15 ± 53.23 0.392
ICD-10 classification F1 (%) 0 (0) 1 (1.5) 0.804
F2 (%) 0 (0) 6 (9.1)
F3 (%) 9 (69.2) 42 (63.6)
F4 (%) 2 (15.4) 12 (18.2)
F6 (%) 1 (7.7) 3 (4.5)
Others (%) 1 (7.7) 2 (3.0)
Mean length of hospital stay ± S.D. (days) 251.08 ± 283.27 37.18 ± 37.93 0.000†
Mean number of HBO sessions ± S.D. (sessions) 51.62 ± 16.69 5.38 ± 7.70 0.000†
*Total number of cases may be different for different items.
1) #Chi-square test.
2) †ANOVA (one way analysis of variance).
3) *Mann-Whitney test.
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significantly different between the two groups.
Discussion
Patients’ background and circumstances
It has been reported that aging promotes DNS as a compli-
cation of CO poisoning [8], and that no DNS-developing
cases were seen in patients younger than 30 years of age
[10]. Based on these reports, we initially expected that in-
creased general fragility caused by aging may lead to the de-
velopment of DNS. However, in the present study the
youngest DNS case was 23 years old and, although themean age tended to be higher in the DNS-developing group,
there was no significant difference in mean age between the
DNS-developing and non-DNS-developing groups.
The location of exposure was generally classified as in a
room at home and in a car. Pavese, et al. and O’Donnell,
et al. state that CO gas concentration at the scene multi-
plied by duration of exposure is an important determinant
of the severity of acute CO poisoning [24,25]. While CO
gas concentration is likely to be affected by the size of the
space and the time to filling the space with CO, no signifi-
cant difference was observed in place of exposure or esti-
mated duration of exposure.
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be affected by the fact that duration of exposure was
known only for half of all cases. Specific circumstances of
exposure were varied, such as a case who had prolonged
exposure to CO by burning briquettes in a car and fre-
quently getting in and out of the car to vomit outside, and
another who had prolonged exposure in a well-ventilated
wooden shed. While the product of CO gas concentration
and duration of exposure cannot properly be calculated
without collecting detailed information on individual cir-
cumstances, there is a limit to information available for
collection in acute clinical settings. It is therefore consid-
ered that the wide variety of circumstantial factors in-
volved in space and duration of exposure prevented any
significant difference in these factors from being detected
with respect to the development of DNS.
Physical findings and laboratory results at first consultation
The results show that more severe consciousness disturb-
ance at the time of first hospital consultation is associated
with higher likelihood of developing DNS. There have been
sporadic reports that consciousness disturbance [26] and
prolonged loss of consciousness [10] involved in acute CO
poisoning are risk factors for developing DNS. Acute CO
poisoning resulting from attempted suicide is often com-
bined with other means of suicide attempt, such as alcohol
use or drug abuse, and these multiple factors may result in
aggravation or prolongation of consciousness disturbance.
In the present study, all cases underwent head CT on
the day of admission. Cases with low-density area in the
globus pallidus were significantly more likely to develop
DNS. CO produces parenchymal necrosis in fragile areas
in the cerebral gray matter, particularly bilateral symmetric
necrosis of the globus pallidus, which has been reported
to be characteristic of CO poisoning [8]. Other areas often
affected include the hippocampus, cerebellum and sub-
stantia nigra, where affected parts appear as low-density
areas on CT. While CO gas concentration multiplied by
duration of exposure is considered an important deter-
minant of the severity of acute CO poisoning as men-
tioned above, in clinical settings it is often difficult to
accurately find out how long the unconscious patient has
been exposed to CO. However, a report has proposed a
cut-off value of 570 min as a duration of exposure above
which abnormal CT/MRI findings are predicted to be ob-
served at the initial stage [27]. Using this threshold, it
should be possible to estimate, from head CT findings at
emergency admission, whether or not the patient has had
prolonged exposure. A number of reports have identified
abnormal CT/MRI findings [26] as a risk factor for devel-
oping DNS, which is also the case with this study. On the
other hand, 20% of the cases with no abnormal CT find-
ings did develop DNS, suggesting that even cases without
abnormal findings require attention to the clinical course.Hematology results show that abnormally high CK,
CK-MB and LDH levels are significantly associated with
the development of DNS. In acute CO poisoning cases,
hypoxia and impaired cellular respiration caused by CO
induce damage to multiple organs. These high CK levels
are caused by damage to skeletal muscles. In this regard,
the effect of pressure ulcer formation, which was seen
in a number of cases due to prolonged immobility in
the same position, should also be taken into account.
LDH is an enzyme found in almost all cells and is re-
leased into the bloodstream when cells are damaged. As
such, it is used as an indicator for assessing the severity of
general condition [28]. The high LDH and CK-MB levels
are considered to have been caused by myocardial injury.
While these high levels have both been caused by pro-
longed exposure to CO, the hematological changes ob-
served are regarded as nonspecific and not characteristic
of CO poisoning [11].
The CO -Hb level only indicates the binding ratio be-
tween CO and Hb. As such, it decreases with time once
CO inhalation is stopped, and decreases more efficiently
as a result of oxygen administration in the ambulance. For
this reason, CO-Hb levels following emergency admission
are not directly associated with the degree of systemic tis-
sue damage, as seen in the results of this study, which
failed to show a significant association between CO-Hb
levels and the development of DNS. In fact, the non-DNS-
developing group had a higher mean CO-Hb level. How-
ever, a high CO-Hb level at admission indicates that the
patient has been exposed to correspondingly high levels of
CO, a fact which should be borne in mind in taking mea-
sures in the clinical setting.
Overall, F3 was the most common psychiatric main diag-
nosis according to ICD-10. In the psychiatric assessments
of severity, no significant difference was observed between
the DNS-developing and non-DNS-developing groups in
BPRS score, which assesses the severity of psychiatric
symptoms only, or in LCU score, which assesses the inten-
sity of life events. However, the GAS score was significantly
lower in the DNS-developing group. The GAS is a compre-
hensive functional assessment scale covering psychological,
social and occupational functions, with lower GAS scores
indicating more severe conditions. Assessment was con-
ducted by a psychiatrist who collected, immediately
after admission, information on the immediately preced-
ing circumstances from the patient’s family, etc. In the
DNS-developing group, patients’ overall function was sig-
nificantly poorer. Clinically, the GAS score was independ-
ent of the development of DNS, and a lower GAS score
was not considered to be a predictor for development of
DNS. However, individuals with a lower GAS score may be
profiled as individuals with worsening psychiatric symp-
toms to the extent that they affect physical and social func-
tioning. These individuals may carefully plan to commit
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public view, sealing up a car or room, and combining mul-
tiple methods of suicide. These actions would result in
exposure to CO sufficient to subsequently cause DNS.
Clinical course after hospitalization
Given that the maxim period before the onset of intermit-
tent CO poisoning was 35 days in this study, at least
5 weeks’ follow-up is believed necessary. Length of hos-
pital stay was inevitably longer in the DNS-developing
group, since patients in this group needed time to recover
from DNS. Similarly, the number of HBO therapy sessions
was larger in the DNS-developing group, since approxi-
mately 60 HBO sessions are required once DNS develops.
On the other hand, 62% of all cases and 77% of the
cases in the DNS-developing group received HBO ther-
apy on the day of emergency admission. This suggests
that, despite its efficacy in acute CO poisoning and DNS
cases, HBO therapy may not be able to completely pre-
vent the development of DNS even if administered dur-
ing the initial stage of treatment.
Conclusion
The profile of cases at high risk of developing DNS is ex-
pected to include a clinical picture consisting of: the pa-
tient’s selection of CO exposure as a means of suicide
attempt in such serious mental condition as to affect his/
her social and living functions; serious consciousness dis-
turbance at admission due to acute CO poisoning, with a
JCS score at or above 100; head CT findings indicating hyp-
oxic encephalopathy; and abnormally high CK, CKMB and
LDH levels detected by a blood test. In these cases, active
consideration should be given to HBO therapy from an
early stage after explaining to the patient’s family members
the risk of developing DNS, and at least five weeks’ follow-
up is believed necessary, during which due consideration
should be given to the potential development of DNS.
The results of this study are tentative. Plans are to col-
lect more substantiating data and conduct additional stud-
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